Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab. When the accuracy of the T-SPOT.TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients, benefit from the resultant powerful solution.
Paxlovid is not fully accessible to those who need it most: the immunocompromised
The pandemic is over for most of the world. But for the 2.7% of adults in the United States who are immunocompromised, it isn’t. I’m